RESEARCH TRIANGLE PARK, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (the “Company” or “Science 37”), the clinical research industry’s leading MetasiteTM, today ...
Science 37's new metasiteTM operating model efficiently delivers end-to-end clinical trial services under a single contract by leveraging partnerships with national mobile nursing companies, pharmacy ...
MORRISVILLE, N.C., March 17, 2026 (GLOBE NEWSWIRE)-- Science 37, the leader in expanding patient access to clinical trials, today announced the formal launch of its dedicated Pediatrics Department, ...
MORRISVILLE, N.C., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Science 37, the leader in expanding patient access to clinical trials, and Catalent ®, a global leader in enabling pharma, biotech, and consumer ...
LOS ANGELES & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Science 37 and Foundation Medicine today announced a collaboration to enable decentralized clinical research in oncology that will optimize recruitment ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A clinical research company in ...
Los Angeles-based research company Science 37 announced the completion of a clinical study for AOBiome Therapeutics conducted entirely through a smartphone app. The Phase 2b study ran on the back of ...
Science 37, Inc. will relocate its corporate headquarters from Culver City, CA to North Carolina’s Research Triangle region and create 250 jobs over five years. The clinical research company will ...
37 Medical Director Christopher Reist using the company’s platform. Playa Vista-based Science 37 Inc., a digital clinical trial firm, is becoming a publicly listed company through a merger with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results